Bridging tumor growth dynamics and survival in preclinical oncology drug development - a Tumor Growth Inhibition and Time-to-Event (TGI-TTE) modeling framework.
- DOI
- 10.1007/s00280-026-04947-0
- Published
- 2026-09-12
- Container
- Cancer Chemother Pharmacol
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00280-026-04947-0,
title = {Bridging tumor growth dynamics and survival in preclinical oncology drug development - a Tumor Growth Inhibition and Time-to-Event (TGI-TTE) modeling framework.},
author = {Niloy KK and Horn J and Bhuiyan NH and Bhosale SS and Shaaban KA and Prisinzano TE and Thorson JS and Rohr J and Leggas M.},
year = {2026},
journal = {Cancer Chemother Pharmacol},
doi = {10.1007/s00280-026-04947-0},
url = {https://doi.org/10.1007/s00280-026-04947-0}
}RIS
TY - JOUR TI - Bridging tumor growth dynamics and survival in preclinical oncology drug development - a Tumor Growth Inhibition and Time-to-Event (TGI-TTE) modeling framework. AU - Niloy KK AU - Horn J AU - Bhuiyan NH AU - Bhosale SS AU - Shaaban KA AU - Prisinzano TE AU - Thorson JS AU - Rohr J AU - Leggas M. PY - 2026 JO - Cancer Chemother Pharmacol DO - 10.1007/s00280-026-04947-0 UR - https://doi.org/10.1007/s00280-026-04947-0 ER -
APA
KK, N., J, H., NH, B., SS, B., KA, S., TE, P., JS, T., J, R., & M., L. (2026). Bridging tumor growth dynamics and survival in preclinical oncology drug development - a Tumor Growth Inhibition and Time-to-Event (TGI-TTE) modeling framework.. Cancer Chemother Pharmacol. https://doi.org/10.1007/s00280-026-04947-0
Source records
- europe-pmc · retrieved 2026-09-25T13:11:40.191Z